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Previous research demonstrated the inhalation teratogenicity of the solvent 2-ethoxyethanol in rats and
rabbits. As this is one ofa class ofwidely used industrial solvents, we investigated the teratogenicity offive
structurally related compounds. Each chemical was vaporized and administered to approximately 15
pregnant rats in one to three concentrations for 7 hr/day on gestation days 7 to 15, and dams were sacrificed
on day 20. Fetuses were individually weighed, and two-thirds of them were fixed in Bouin's solution and
examined for soft-tissue anomalies. The other one-third were fixed in alcohol, stained with Alizarin Red
and examined forskeletal defects. Data were analyzed on a litter basis; three solvents were compared with a
pooled group (N = 34) ofsham-exposed controls, and the remaining two were compared with a group of 15
controls. At concentrations which were apparently not maternally toxic, 2-methoxyethanol was highly
embryotoxic, producing complete resorptions at 200 ppm; increased resorptions, reduced fetal weights and
skeletal and cardiovascular defects occurred at both 100 and 50 ppm. 2-ethoxyethyl acetate at 600 ppm
induced complete resorption of litters; 390 ppm reduced fetal weights and induced skeletal and
cardiovascular defects, but only a single defect was observed at 130 ppm. 2-Butoxyethanol evidenced slight
maternal toxicity at 200 ppm but produced no increase in congenital defects at that concentration. Neither
2-(2-ethoxyethoxy)ethanol (100 ppm) nor 2-methylaminoethanol (150 ppm) was maternally toxic or
embryotoxic. In summary, shorter alkyl chained glycol ethers produced greater embryotoxicity than those
having longer chains, and the ester produced effects equivalent to the ether, both patterns predictable from
the biochemical literature.
Of the thousands of chemicals to which workers are
exposed, only a few have even minimal experimental
animal data from which to evaluate or predict
reproductive toxicity. One class of chemicals that has
demonstrated reproductive toxicity is a class of mono-
and dialkyl ethers of ethylene glycol and their
derivatives, collectively referred to as cellosolves or
glycol ethers. Approximately 700 million pounds (318
thousand metric tons) ofglycol ethers were produced in
1977, with the ethylene glycol monoethers representing
about 78% of the total production (1). Ethoxyethanol,
the prototype of this class, has the largest production
volume, followed by butoxyethanol and methoxyethanol
(1). The glycol ethers are widely used in industry as
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solventsfornitrocellulose, lacquers, inks, dyes, enamels,
varnishes, varnish removers, and dry cleaning com-
pounds. In addition, they are used in some commercial
products such as cosmetics and liquid household
cleaners. Produced and distributed by at least six major
American chemical companies, the glycol ethers have a
combined potential exposure population of around 1.5
million workers in the United States.
The earliest evidence of reproductive toxicity of this
chemical group was observed when skeletal defects
were reported in offspring of rats following 100
,ug/kg/day IP injections of ethoxyethanol throughout
gestation, although no defects were noted in mice or
rabbits (2). The same investigators administered
ethoxyethanol at 400 ,uL/kg/day for 4 weeks or 200
,uL/kg/day for 13 weeks to male rats and observed
testicular damage after both exposure regimens. Re-
cently increased skeletal variations were observed fol-
lowing intubation of doses as low as 31.25 mg/kg/day
methoxyethanol on gestation days 7 to 14 in mice (3).
Only recently, however, have there been reports of
teratogenic effects produced by the glycol ethers afterNELSON ET AL.
administration using the common routes ofoccupational
exposure, inhalation and cutaneous absorption. Skeletal
and cardiovascular defects were observed in rats after
dermal exposure to 1.0 mL (0.25 mL, four times/day)
ethoxyethanol on gestation days 7 to 16, with nearly
halfofthe litters entirely resorbed at that level, and all
litters completely resorbed at twice that level (4).
Gestational exposure via inhalation to 600 to 750 ppm
ethoxyethanol produced complete embryomortality in
rats and rabbits, whereas 200 or 160 ppm ethoxyethanol
induced skeletal and cardiovascular defects in rats and
rabbits, respectively (5). Increased neonatal mortality
following inhalation exposure of pregnant rats to
ethoxyethanol at the current Federal occupational stan-
dard (200 ppm) and behavioral and neurochemical
alterations in the offspring of pregnant rats exposed to
one-half that concentration (viz. 100 ppm) have been
reported (6).
Dose-dependent increases in testicular atrophy have
been reported in mice following oral administration of
various glycol ethers at 250 to 4000 mg/kg/day, 5
days/week for 5 weeks (7). The lowest levels causing
significant deviations from controls were as follows:
methoxyethanol 250 mg/kg, methoxyethyl acetate 500
mg/kg; ethoxyethanol 1000 mg/kg, ethoxyethyl acetate
1000 mg/kg; butoxyethanol and phenoxyethanol pro-
duced mortality in all rats at 2000 mg/kg but had no
effect on testicular weight at 1000 mg/kg. The most
important implication of these results is the indication
that the chemicals having shorter attached alkyl groups
produced the most damage and that reproductive toxic-
itydecreaseswithincreasingchainlength. Esterification
of the compounds (i.e, the acetate forms) resulted in
less testicular atrophy when the dose was calculated on
a weight per body weight (mg/kg) basis (at least with
methoxyethanol), but produced effects equivalent to
those of the alcohol form when calculated on a molar
basis (thus implying that the acetate was removed prior
to the toxic action).
The present research evaluated the teratogenic ef-
fects of structurally related glycol ethers in an attempt
to determine the structure activity relationships for
teratogenicity. Table 1 presents the glycol ethers evalu-
ated for teratogenicity in the present research, along
with the same data for ethoxyethanol. As seen from the
table, a chemical having a shorter alkyl chain was
selected (methyl rather than ethyl), as was one with a
longer chain (butyl), and were the diethylene glycol
ethyl ether and the ethyl acetate. The latter was chosen
rather than the ether in order to verify that the acetate
would produce effects equivalent to the ether, as would
be predicted from the ubiquitous nature of esterases
within the body and as shown for the male reproductive
effects cited above. Finally, the amino analog of
methoxyethanol was tested to determine the structural
specificity required to produce teratogenic effects.
Materials and Methods
Subjects
Virginfemale and male Sprague-Dawleyratsspecified
to be free of mycoplasma and Sendai virus and of
internal and external parasites (Charles River Breeding
Laboratories, Wilmington, MA) were acclimated to a
12-hr light-dark cycle (lights on at 6 am) and to a
temperature of24 + 2°C for 2 weeks. The humidity, not
controlled, typically was in the range of 40 + 20%.
Purina Lab Chow and tap water were available ad
libitum except when pregnant animals were in expo-
sure chambers. Bedding consisted of cleaned, heat-
treated sawdust from a local supplier (Absorb-Dri,
Tasty Foods, Cincinnati, OH).
Apparatus and Procedures
Males weighing over 300 g were placed individually
into a cage with three females weighing 200 to 300 g.
Table 1. General information on the glycol ethers included in the present research.
Rat toxicity data
Common name Skeleton Oral, g/kg Inhalation, ppm/hr OSHA Standard NIOSH estimated
and formula formula LD50 LCL (TWA), ppm exposure population
2-Methoxyethanol
CH3OC2H4OH C-O-C-C-OH 2.46 2000/4H 25 97,285
2-Ethoxyethanola C-C-O-C-C-OH 3.0 4000/4H 200 359,790
C2H5OC2H4OH
2-Ethoxyethyl acetate 0
C2H5OC2H402C2H3 C-C-O-C-C-O-C-C 5.1 3000/4H 100 231,970
2-Butoxyethanol
C4HqOC2H4OH C-C-C-C-O-C-C-OH 1.48 500/4H 50 1,279,707
2-(2-Ethoxyethoxy)-
ethanol (carbitol) C-C-O-C-C-O-C-C-OH 6.5 None None 20,000
C2H5OC2H4OC2H4OH
2-Methylaminoethanol
CH3NHC2H4OH C-N-C-C-OH 2.34 None None Unknown
aInvestigated in previous research.
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Vaginal smears were taken each morning, and the
presence of sperm marked day zero ofgestation. These
females were placed alone in38 x 33 x 17-cmpolycarbo-
nate cages with filter tops. Feed and water intake and
maternal weight were recorded weekly (i.e., on days 7,
14, and 21); any other signs of maternal toxicity were
noted daily.
The glycol ethers (technical grade, 98 to 99.5% pure;
Eastman Kodak Co., Rochester, NY) were heated in a
flask set in hemispherical mantles. Vaporization was
achieved by bubbling air through each solvent which
was heated to approximately 40°C (for the higher
concentrations). This vapor was thenmixedwithfiltered
room air to obtain the desired concentration and intro-
duced into 0.5 m3 exposure chambers (Charles Spengler
and Associates, Cincinnati, OH). The concentration was
continually monitored by a Miran I infrared spectropho-
tometer (Foxboro Analytical, South Norwalk, CT) with
the concentration recorded hourly. Typically, two or
three charcoal tube samples (silica gel tubes for 2-
methylaminoethanol) were taken weekly from the cham-
ber air for independent verification ofthe concentration
by gas chromatograph. Two exceptions are noted below
where more were taken (9). Throughout this paper
concentrations are expressed in parts of solvent per
million parts of air; hence values for the different
chemicals are comparable on a molar equivalent basis.
Air flow through the chambers provided approximately
four air changes per minute. Exposures were conducted
sequentially in one or two chambers, with a third
chamber for sham exposure of control subjects.
Pregnant females were transported from the animal
quarters to the inhalation chambers in their home cages
with filter tops (Hazleton Systems, Aberdeen, MD).
They were placed individually in 13 x 25 x 189-cm
stainless steel wire mesh cages within exposure
chambers. Control animals were placed in similar cham-
bers for the same hours as the exposed animals; a
pooled group of controls (N = 34) served as the
comparison group for the first three chemicals
examined. Another group of 15 controls served as the
comparison group for the last two chemicals examined,
as these groups were exposed at a later time
(approximately 6 months later) than the first three.
Exposures, as outlined above, were conducted 7 hr/day,
and the animals were left in the chamber for at least one
additional hour blow-off time after vapor generation
terminated. They were then returned in their individual
housing cages to the animal quarters, where water
bottles were replaced. Exposures were conducted on
gestation days 7-15. On day 20, the females were
individually weighed and euthanized by chloroform
asphyxiation. The entire uterus was removed and num-
bers of resorption sites (classified as early, middle or
late) and live fetuses wvere determined. Fetuses were
serially removed, blotted of excess fluids, weighed,
examined for external malformations and external sex
determined. One third of the fetuses were randomly
selected and placed in 95% ethanol, and the remaining
fetuses were placed in Bouin's solution. After being in
the Bouin's solution for at least 1 week, these fetuses
were examined for visceral abnormalities using Wilson's
razor blade sectioning technique (10). The viscera were
examined with the aid of a dissecting microscope. A
representative sample of sections with malformations
was identified by dam number and saved in 70% alcohol.
Fetuses were examined for skeletal defects by using a
modified Staples technique (11). They were fixed in 95%
alcohol, eviscerated and macerated in 2% KOH/Alizarin
Red S solution. The fetuses were further macerated and
cleared in the appropriate solutions of2% KOH/glycerin
(60:40, 40:60, 20:80) and stored in 100% glycerin. A
crystal of thymol was added to each storage vial to
retard fungal growth. Storage vials were individuallv
identified by dam number.
Statistical Analysis
Numbers of implants and proportions of resorptions
were independently analyzed by using a Kruskal-Wallis
Table 2. Concentrations of vapors generated in inhalation study.
Vapors generated, ppm
Days of By infrared By gas chromatography
exposure (X ± SD) (X ± SD)
Methoxyethanol 11 199.2 ± 0.98 b
29 101.4 ± 2.2 99.3 ± 16.3
19 50.6 ± 1.0 47.4 ± 5.9
Butoxyethanol 11 194.4 ± 6.1 b
20 153.3 ± 6.8 176.8 ± 8.3c
Ethoxyethyl acetate 12 601.0 ± 3.47 594.9 ± 109.9
21 a 387.2 ± 8.7
12 a 128.9 ± 1.a
2-(2-Ethoxyethoxy) ethanol 29 a 102.2 ± 15.6
2-Methylaminoethanol 28 a 150.0 ± 15.2
aDue to equipment problems, suitable data for concentrations from the infrared analyzer were not available for these chemicals.
bGas chromatograph samples were not taken in these exposures. cThis charcoal tube result is approximately 15% higher than that from the infrared analyzer (IR); since the IR provided an essentially con-
tinuous daily record of exposures, we have used the figures (usually rounded to the nearer 10 ppm) from the IR throughout the text for all
chemicals where suitable datafrom the IR were available. Where IR datawere notavailable, the charcoaltube results were used within the text.
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test corrected for ties, with subsequent multiple com-
parisons to determine where the differences occurred
(12). Analysis of pup weights involved a mixed model
analysis of covariance (with the number of live pups in
the litter as the covariate) using maximum likelihood
estimation (13,14). The model was mixed, since there
was both within-litter and between-litter variation.
Subsequently, pairwise comparisons between the pooled
control group and each treatment group were
performed. Incidence of total defects and of total
variants were compared using a Kruskal-Wallis test
with multiple comparisons (12) with the litter as the
experimental unit and the level of significance at
p< 0.05.
Results
The concentrations within the exposure chambers as
measured by the infrared analyzer were relatively close
to those obtained from gas chromatography (Table 2).
Control
No visceral or skeletal malformations were observed
in fetuses from control dams. The types of visceral and
skeletal variants observed in fetuses from the control
treated dams were similar to those variants observed in
chemically exposed groups.
Methoxyethanol (ME)
Concentrations ofME (Table 2) were easily generated
and were rapidly cleared from the exposure chambers.
There were no overt signs of toxicity in the pregnant
rats in any of the groups. The only weight decrements
in the maternal animals were likely due to increased
resorptions. As shown in Table 3, all litters at the
highest concentration (200 ppm) were entirelyresorbed.
At 100 ppm, about half of the litters (18 of 34) were
entirely resorbed, and all litters had some resorptions;
the mean weight of the live fetuses was reduced by
approximately one-third from the control value. At 50
ppm there was approximately a 3-fold increase in
resorptions and fetal weights were reduced by 20%
compared to the control values.
Visceral malformations (Table 4) were found in fe-
tuses from both the 50 ppm and 100 ppm ME-treated
dams, but only the incidence ofthose from the 100 ppm
group was significantly different from the controls (p S
0.025). Heart abnormalities were the predominant mal-
formations observed in both the 100 ppm and 50 ppm
ME groups. Malformations ofthe retina, eye, umbilicus
and lungs of ME-exposed fetuses were also observed
but at a frequency lower than the aforementioned.
Wavy, fused, and absent ribs, plus extra vertebrae
were observed in the 100 and 50 ppm ME treatment
groups (Table 5). Additionally, tail malformations were
observed in the 100 ppm group. Statistical analyses of
these pooled data indicate significant differences from
controls for both the 50 ppm (p < 0.025) and 100 ppm
(p < 0.05) treatment groups. Fetuses in the 50 ppm
group demonstrated more rib malformations than fe-
tuses in the 100 ppm group. The failure ofthe incidence
of malformations to increase with dose may be the
result of increased embryo lethality observed in the
high dose group. These data indicate that inhalation of
50 or 100 ppm ME is teratogenic in the rat.
Table 3. Effects of maternal exposure to glycol ethers on pregnancy outcome.
2-Methoxyethanol
Number pregnant/number mated
Implants/dam (X)
Litters with resorptions, %
Resorptions/litter (X)
Controls 50
ppm
34/41 14/17
12.7 12.5
14 9
(42) (64)
0.64 1.6a
100
ppm
34/38
12.5
34
(100)
9.8a
200
ppm
8 /11
12.6
8
(100)
12.6a
2-Butoxyethanol
150 200
ppm ppm
16/19 15/18
12.9 15.1a
4 9
(25) (60)
0.23 1.2
2-Ethoxyethyl acetate
130 390 600
ppm ppm ppm
15/15 15/20 9/9
14.5a 12.9 14.7a
7 9 9
(47) (56) (100)
0.49 2.3a 14.7a
Resorptions
Early
Middle
Late
Tbtal
(% of implants)
Tbtal live fetuses
Live fetuses/litter (X)
(% of implants)
Live fetal weights (X)
Female
Male
Standard error of meanb
21 15
1 2
1 2
23 19
(5) (11)
192
77
61
330
(77)
407 156 96
12.2 11.1 2.8
(95) (89) (23)
3.46 2.84a 2.29a
3.64 2.91a 2.49a
0.07 0.07 0.28
101
(100)
4 16 8 20
0 1 0 7
0 1 0 8
4 18 8 35
(2) (8) (4) (17)
0 206 203 211
0 12.6 13.9 14.0
(98) (92) (96)
175
10.8
(83)
78
19
6
103
(100)
0
0
3.28a 3.49 3.31a 2.74a
3.55a 3.66 3.46a 2.85a
0.10 0.10 0.10 0.10
aSignificantly different from controls at p < 0.05 (only data on implants, X resorptions, and fetal weights were analyzed).
bIn no case was there a significant difference between sexes on this variable; hence, only the larger is presented.
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Table 4. Visceral malformations.
ME BU EEAC
50 100 150 200 130 390
Controls ppm ppm ppm ppm ppm ppm
Number of litters 34 14 11 16 15 15 15
Number of fetuses examined 270 103 65 135 135 142 116
Cardiac malformation, no. (%)
IV septal defect 0 4(4) 13(20) 0 0 0 6(5)
Ringed aortic arch 0 1(1) 4(6) 0 0 1(1) 2(2)
Rt.-sided aortic arch 0 1(1) 1(2) 0 0 0 0
Rt.-sided ductus arteriosus 0 0 0 0 0 0 1(1)
Pulmonary valve stenosis 0 0 1(2) 0 0 0 0
TImcus arteriosus communus 0 0 1(2) 0 0 0 0
Levocardia 0 0 1(2) 0 0 0 0
Pulmonary malformations
Hypoplastic lungs 0 0 2(3) 0 0 0 0
Optical malformation
Deformed retina 0 1(1) 0 0 0 0 0
Reduced eye size 0 0 1(2) 0 0 0 0
Miscellaneous
Umbilical hernia 0 1(1) 0 0 0 0 2(2)
Tbtal fetuses normala 191 55 27 104 99 95 55
Ibtal fetuses malformed 0 8 19 0 0 1 7
Tbtal litters affected 0 6 10 0 0 1 3
Statistical significance NSb p < 0.025 NS NS NS p < 0.01
aNormal defined as having no visceral variations or malformations.
bNS = not significant at p = 0.05.
Table 5. Skeletal malformations.
ME BU EEAC
50 100 150 200 130 390
Control ppm ppm ppm ppm ppm ppm
Number of litters 34 14 9 16 15 15 15
Number of fetuses examined 137 53 31 68 71 69 59
Vertebra malformations, no. (%)
Extra 0 0 2(6) 0 0 0 0
Ribs
Rudimentary 13tha 0 0 0 1(1) 0 0 0
Wavy 0 15(28) 5(16) 0 0 0 2(4)
Fused 0 2(4) 0 0 0 0 1(2)
Absent 0 1(2) 0 0 0 0 0
Tail
Shortened 0 0 4(6) 0 0 0 0
Absent 0 0 1(2) 0 0 0 0
Total fetuses normalb 137 2 1 37 52 30 2
Tbtal fetuses malformed 0 16 10 0 0 0 4
Total litters affected 0 8 4 0 0 0 3
Statistical significance p < 0.025 p < 0.05 NSC NS NS p < 0.01
aConsidered a minor malformation.
bNormal defined as having no skeletal malformations or deviations.
CNS = not significant at p = 0.05.
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Table 6. Visceral variations.
ME BU EEAC
50 100 150 200 130 390
Control ppm ppm ppm ppm ppm ppm
Number of litters 34 14 11 16 15 15 15
Number of fetuses examined 270 103 65 135 135 142 116
Cranial variations, no. (%)
Enlarged lateral ventricles 5(2) 21(20) 24(37) 0 5(4) 7(5) 22(19)
Cardiac
Enlarged atria 0 0 1(2) 0 0 0 0
Urogenital
Hydronephrosis 4(2) 1(1) 2(3) 2(1) 3(2) 6(4) 6(5)
Bilateral 1 0 1 2 1 1 5
Unilateral 3 1 1 0 2 5 1
Dilated renal pelvis 39(14) 23(22) 2(3) 13(10) 19(14) 25(18) 14(12)
Bilateral 13 16 2 7 9 13 7
Unilateral 26 7 0 6 10 12 7
Low set kidney 6(2) 0 0 0 1(1) 2(1) 8(7)
Hypoplastic kidney 0 0 0 0 0 0 1(1)
Hydroureter 52(19) 8(8) 3(5) 17(13) 12(9) 34(24) 19(16)
Bilateral 21 5 1 9 3 25 11
Unilateral 31 3 2 8 2 9 8
Misplaced testes 20(7) 11(11) 5(8) 10(7) 12(9) 5(4) 10(9)
Bilateral 5 1 1 0 1 1 2
Unilateral 15 10 4 10 11 4 8
Tbtal fetuses normal 191 55 27 104 99 95 55
Total fetuses with variations 79 44 31 31 36 47 58
TItal litters affected 26 13 10 12 13 14 15
Statistical significance p < 0.01 p < 0.01 NSa NS NS p < 0.01
aNS = not significant at p = 0.05.
Visceral variants observed in fetuses from both
ME-treated groups were similar to those variants
observed in control fetuses (Thble 6); however, their
frequency in exposed groups was significantly increased
above that for the control group (p < 0.01). Skeletal
variants were significantly more numerous in fetuses
from both the 50 (p < 0.01) and 100 ppm (p < 0.025)
ME-exposed dams than were variants in fetuses from
control dams (Table 7). These data indicate that
inhalation of ME did cause growth retardation in the
rat.
Butoxyethanol (BU)
Concentrations ofBU were more difficult to generate
in that the solvent required heat to generate even the
low concentrations. Clearance time from the chambers
was also longer than for ME. This was the only one of
the chemicals which produced apparent maternal toxic-
ity [ranging from hematuria, as has been reported in
the literature (15), to death at concentrations from
250 to 500 ppm. Based on the maternal toxicity,
In a dose finding study conducted at the outset of the project,
nonpregnant rats (250-300 g) were exposed to 250, 350 or 450 to 500
ppm BU (no charcoal tube verification). Three offour rats exposed to
450 to 500 ppm ofBU for 6.5 hr died within 36 hr after termination of
exposure levels of 150 and 200 ppm were chosen for
the teratology study.
Pregnant rats exposed to 200 ppm BU showed some
hematuria, but only on the first day of exposure. With
that exception, the dams showed no adverse effects.
There was a significant increase in the mean number of
implants in the 200 ppm BU group, but since no
treatment began until day 7, this increase was not
treatment-related. There was also no apparent adverse
effect upon the pups, as the numberofresorptions, fetal
weights, and incidence of malformations did not differ
from controls (Tables 3-7). (There was a statistically
significant decrease in fetal weights in the 150 ppm BU
groups, but since the differences were slight and there
were no effects at the higher level, these differences
exposure, and two of three nonpregnant rats died within 18 hr after
exposure to approximately 350 ppm BU for 7 hr. Of three nonpreg-
nant rats exposed for 7 hr to 250 ppm BU, one died within 18 hr after
exposure, and a second died after day 2 of exposure. With each of
these concentrations, the exposed rats began showing various (le-
grees of hematuria 4 to 6 hr after onset of exposure, as has been
reported elsewhere (15). From each of these concentrations, one
rat survived, and these three animals were placed together in a
41 x 32 x 18-cm steel cage. Approximately 1 week after exposure,
the distal portion of the tail (about one-half the tail length) became
necrotic and fell offor was chewed off. Observations ofa small number
of singly housed rats exposed cutaneously to butoxyethanol woul(d
suggest that each rat chewed its own tail off.
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Thble 7. Skeletal variations.
ME BU EEAC
50 100 150 200 130 390
Control ppm ppm ppm ppm ppm ppm
Number of litters
Number of fetuses examined
Skull variations, no. (%)
Incomplete ossification
Frontal
Parietal
Interparietal
Supraoccipital
Maxilla
34
137
14
53
1(1) 16(30)
3(2) 16(30)
3(2) 15(28)
2(2) 17(32)
0 0
9 16 15
31 68 71
4(13) 0
15(48) 0
12(39) 1(1)
18(58) 0
5(16) 0
1(1)
1(1)
0
0
0
Vertebra
Absent
Sacral/caudal
Incomplete ossification
Thoracic
Lumbar
Sacral/caudal
Centra
Absent
Thoracic
Lumbar
Sacral/caudal
Incomplete ossification
Thoracic
Lumbar
Sacral/caudal
Abnormal
Thoracic
Lumbar
Sacral/caudal
0
0
0
20(15)
0
0
0
0
0
0
6(4)
0
0
35(66)
0
1(2)
21(40)
14(26)
0
23(43)
0
0
1(2)
40(75)
16(30)
3(6)
3(10) 4(6)
0 0
0 0
12(39) 9(13)
16(52) 0
1(3) 0
5(16) 0
0 0
0 0
0 0
21(68) 15(22)
16(52) 0
3(10) 0
Sternebrae
4-incomplete ossification
Abnormal
2(2)
1(1)
Ribs
Rudimentary 14th
Pelvic girdle
Pubis
Absent (not ossified)
Incomplete ossification
Illium
Absent (not ossified)
Incomplete ossification
Ischium
Absent (not ossified)
Incomplete ossification
5(4)
1(1)
0
0
0
0
2(2)
Other
Metacarpals (3 ossified)
Total fetuses normal
Tbtal fetuses with variations
Total litters affected
0
100
37
19
Statistical significance
"NS = not significant at p = 0.05.
b130 ppm vs. 390 ppm, p < 0.05.
17(32)
11(21)
4(8)
9(17)
3(6)
0
0
1(2)
11(21)
19(36)
2
50
13
23(74) 3(4)
5(16) 1(1)
14(45) 3(4)
6(19) 0
5(16) 0
12(39) 0
5(16) 0
9(29) 0
6(19) 0
12(39) 0
1 37
30 31
9 10
p < 0.01 p < 0.025 NSa
0 1(1) 12(21)
0 0 5(9)
9(13) 10(14) 36(63)
0 1(1) 2(4)
0 0 0
0 0 0
0 1(1) 7(12)
0 0 0
0 1(1) 3(5)
O 1(1) 11(19)
52 30 2
19 39 56
8 14 15
NS p < 005b p < 0.01
15
69
15
59
1(1)
1(1)
1(1)
1(1)
0
12(21)
12(21)
10(17)
11(19)
0
0
0
0
7(10)
0
0
0
0
0
0
7(10)
1(1)
0
0
0
0
22(32)
1(1)
0
0
0
0
5(7)
11(16)
0
0
2(4)
0
0
26(46)
17(30)
0
1(2)
0
0
8(14)
32(56)
17(30)
0
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Table 8. Effects of maternal exposure to 2-(2-ethoxyethoxy)ethanol (2-EEE) or 2-methylaminoethanol (2-MAE) on pregnancy outcome.
Controls 2-EEE 2-MAE
Number pregnant/number mated 15/16 20/21 18/24
Implants/dam (X) 13.1 13.4 11.9
Litters with resorptions (%) 10(67) 12(60) 10(56)
Resorptions/litter (X) 1.3 0.9 0.7
Tbtal live fetuses 174 250 212
Live fetuses/litter (X) 11.6 12.5 11.8
(% of implants)
Live fetal weights (FX)
Female 3.26 3.19 3.59
Male 3.33 3.25 3.69
Standard deviation 0.30 0.25 0.31
Number (%) of litters 5(33) 6(30) 7(39)
with abnormal fetusesa
aLitter with at least one fetus having either skeletal or visceral anomalies; detailed in Tables 9 and 10.
Table 9. Summary of visceral observations after exposure to 2-(2-ethoxyethoxy)ethanol or 2-methylaminoethanol.
Number of litters (fetuses)/percenta
Control 2-EEE 2-MAE
Number of litters 15 19 18
Number of fetuses examined 116 166 143
Malformations
Cardiovascular:
Double aortic arch 0 1(1)/.53 0
Missing innominate 0 1(1)/.53 0
Brain:
Hydrocephalus (mild) 3(6)/8 1(4)/4 3(5)/4
Variations
Testicular: (number males examined) 62 76 74
Undescended testes 0 0 1(l)/i
Position variation 10(22)/39 13(17)/22 9(13)/17
Urinary:
Dilated renal pelvis 3(4)/3 7(13)/7 5(5)/3
Dilated ureter 3(6)/5 9(19)/11 6(18)/11
Hydronephrosis 2(2)/2 3(4)/3 0
Hydroureter 3(3)/2 4(7)/4 5(6)/4
Ectopic kidney 1(1)/i 2(2)/1 0
Other:
Abdominal hemorrhage 1(l)/i 1(l)/i 0
Liver hemorrhage 0 1(1)/i 0
Number of fetuses with variations 30 43 27
Percent normalb,c 89 ± 26 91 ± 21 92 ± 15
Number of fetuses 107 153 131
Percent abnormalb 11 ± 26 9 ± 21 8 ± 15
Number of fetuses 9 13 12
aMean of litter mean percent.
bMean of litter mean percent ± SD.
cIncludes fetuses with variations.
were likely not of biological significance.) After expo-
sure to 150 ppm BU, rats occasionally showed slight
hematuria on the first day of exposure, but no other
adverse effects were noted in the dams or pups; one
fetus with cephalothoracomphalopagus was observed,
but this was likely a chance occurrence and not
treatment-related.
2-Ethoxyethyl Acetate (EEAC)
Concentrations of EEAC were relatively easy to
generate and cleared rapidly from the chamber. Mater-
nal animals showed no overttoxicity; aweight reduction
was observed at higher concentrations, but this was
likely due to increased resorptions. As shown in Table
3, all offspring from dams exposed to 600 ppm EEAC
were resorbed. At 390 ppm there was a significant
increase in resorptions and fetal weights were reduced
by21%, and at 130 ppm there were slight but significant
decreases in fetal weights.
Visceral malformations of the heart and umbilicus
were observed in fetuses from the 390 ppm EEAC-
treated dams (Table 4). Only one fetus fromthe 130 ppm
group had a heart defect. Statistical analysis ofthe data
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T!able 10. Summary of skeletal observations after exposure to 2-(2-ethoxyethoxy)ethanol or 2-methylaminoethanol.
Number of litters (fetuses)/percenta
Control 2-EEE 2-MAE
Number of litters 14 19 18
Number of fetuses examined 58 84 69
Malformations
Missing ribs 0 1(1)/1 0
Decreased thoracic vertebrae 0 1(1)/1 0
Variations
Ribs:
Rudimentary 14th 1(1)/2 5(7)/8 1(2)/4
Rudimentary lumbar 0 0 1(1)/1
Skull:
Incomplete ossification
Supraoccipital 0 1(1)/1 1(1)/1
Interparietal 1(1)/2 2(2)/3 1(2)/2
Parietal 1(1)/2 3(3)/4 0
Frontal 0 2(2)/3 0
Sternebrae:
Decreased number ( < 4) 1(1)/2 1(1)/1 0
Split 0 0 1(1)/1
Misaligned 1(1)/2 6(6)/7 5(5)/7
Centra
Thoracic
Missing, half-sized 0 4(4)/5 0
Misshapen 1(1)/2 3(3)/3 5(5)/8
Appendages
Decreased metatarsals ( < 4) 0 3(3)/4 0
Decreased metacarpels ( < 3) 0 1(1)/1 0
Pelvic girdle
Pubis, missing, pinpoint 0 1(1)/1 2(2)/3
Ischium, missing, reduced size 0 1(1)/1 1(1)/1
Number of fetuses with variations 4 23 16
Number of fetuses with no variations 14(54)/93 19(61)/73 18(53)/77
or malformations
Percent normalb,e 100 ±0 99 ± 6 100 ±0
Number of fetuses 58 83 69
Percent abnormal 0 1(6) 0
Number of fetuses 0 1 0
'Mean of ltter mean percent.
bMean of litter mean percent ± SD.
'Includes fetuses with variations.
indicated significant differences between EEAC treated
and control groups (p < 0.01); furthermore, since heart
defects rarely occur spontaneously, and none were
observed in control fetuses, these data indicate that
inhalation of either 130 ppm of 390 ppm EEAC is
teratogenic in the rat.
Malformations of the ribs were observed in three
fetuses from 390 ppm EEAC-exposed dams (Table 5); no
skeletal malformations were observed in fetuses from
the 130 ppm EEAC group. Statistical analysis of these
data indicated significant differences from the controls
(p < 0.01); however, due to the low frequency of
occurrence of these malformations, treatment-induced
cause cannot be positively concluded.
Visceral variants observed in fetuses from EEAC-
treated dams were similar to those variants observed in
control fetuses (Table 6); however, the frequency of
variants in the exposed groups was significantly
different from the control-treated group Significant
statistical differences in skeleltal variants (Table 7) were
observed between control and 130 ppm (p < 0.05) and
390 ppm (p < 0.01) and also between 130 ppm and 390
ppm treatment groups (p < 0.01). (p < 0.05). These
data indicate that inhalation of EEAC at either dose
level during the period of organogenesis can cause
growth retardation in the rat.
2-(2-Ethoxyethoxy)ethanol
(Carbitol, 2-EEE)
Due to the low vapor pressure of 2-EEE, higher
concentrations could not be tested due to probable
formation of an aerosol (this was observed during
chamber calibration). No toxicity was observed in
maternal animals or in the offspring (Tables 8-10) after
exposure to 100 ppm 2-EEE (mean concentration from
65 charcoal tubes or 2 to 3 per day = 102 ppm).
Consequently, 2-EEE is likely not a teratogenic hazard
after inhalation exposure. Nor is it of teratogenic risk
when given in comparable molar equivalents to a
cutaneously teratogenic (4) level of ethoxyethanol
(Nelson, unpublished observations).
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2-Methylaminoethanol (2-MAE)
Low vapor pressure also prevented our generating
high concentrations of 2-MAE. At 150 ppm 2-MAE
(mean concentration from 28 silica gel tubes, one per
day, analyzed in duplicate = 150.0 ppm), no maternal or
fetal toxicity was observed (Tables 8-10).
Discussion
In this study of the inhalation teratogenic effects of
four glycol ethers and an amino derivative, methoxy-
ethanol was the most embryotoxic; ethoxyethyl acetate
was less potent; but butoxyethanol, 2-(2-ethoxyethoxy)-
ethanol, and 2-methylaminoethanol were not embryo-
toxic atthe concentrations tested. Congenital malforma-
tions in mice have been reported after the mice were
intubated with various levels of ME on gestation days
7-14 (3). Comparing the frequency of resorptions in
that study with the frequency of resorptions we
observed, it appears that our level of 100 ppm ME
would roughly correspond to their dose of250 mg/kg. At
one half that level (50 ppm and 125 mg/kg) in both
studies, there was little increase in resorptions, but
malformations were observed. Since the study in mice
(3) found malformations at levels lower than this (even
at their lowest dose of 31.25 mg/kg), it is possible that
malformations could be induced by concentrations lower
than our low level of 50 ppm.
The results from ethoxyethyl acetate were as
expected. Based upon the ubiquitous nature of the
esterases within the body, and upon work with testicu-
lar atrophy (7), we had predicted at the outset of the
study that, calculated on a molar basis, EEAC would
have precisely the same effects as ethoxyethanol (EE).
Consequently, 600 ppm EEAC was expected to, and
did, induce complete embryomortality as 600 ppm EE
had done (5,16). At 390 ppm EEAC, resorptions were
only slightly increased, though fetal weights were
depressed and malformations were observed. At 130
ppm EEAC, fetal weights were still depressed and
there was one defective fetus, indicating that this level
is near the teratogenic threshold but should still be
considered teratogenic in the rat. Thus, there is a
relatively steep dose-effect curve with EEAC, and the
same can be said of 2-ethoxyethanol and ME.
Butoxyethanol appears to be rather unique in this
series, in that it produces maternal toxicity at levels
below those which produce embryotoxicity. Its toxicity
and hemolytic effects have been described (15), with a
recent study verifying and extending the previous
report (17). The same investigators also indicated (15)
that the likely metabolic product is butoxyacetic acid,
and that the majority of the metabolite is excreted
within 24 hr. That the excretion is fairly rapid is also
suggested from our results in that the hematuria was
observed only on the first day of exposure. As is
apparently true with most of the glycol ethers, BU is
readily absorbed through the skin (18). Our incidental
observation of necrosis in the tails of rats exposed to
BU was not noted in the literature. Whether the
necrosis was due to damage in the extremity of the
peripheral nervous system (in the tail) or to the lack of
oxygen and nutrients provided by the blood of the
region is unknown, though the known effects of BU on
the blood suggest the latter as a strong possibility.
Theoretically, one of the biotransformation products
of2-EEE would be 2-ethoxyethanol (or its biotransfor-
mation products). Thus it may be that high levels of
2-EEE would be teratogenic, though this remains as
only speculation since we could not generate higher
levels of 2-EEE as a vapor. Considering all of these
results in conjunction with the previously reported
teratogenic effects of 2-ethoxyethanol, it appears that
longer chain glycol ethers are less embryotoxic than the
short-chain glycol ethers; this would be expected due to
the relatively lower lipid solubilities of the longer chain
compounds (19). Further, based on our results with
2-ethoxyethyl acetate, it is likely that the acetates of
other glycol ethers would have similar reproductive
toxicity to their corresponding ethers.
Finally, the lack ofteratogenic response of 2-methyl-
aminoethanol was interesting and from a mechanistic or
theoretical point of view, would merit follow up using a
different route of exposure. At first glance, one might
expect that its biotransformation would be similar to
that of 2-ME. However, our results of no maternal or
fetal toxicity at 150 ppm 2-MAE suggest that this may
not be the case; since the amine is likely more lipid-
soluble and lesswater-soluble thanthemethoxyportion,
the absorption and excretion of the 2-MAE is likely
quite different from that of 2-ME. Thus it would be of
interest to see if a higher dose of 2-MAE would be
teratogenic, though a route other than inhalation would
be required, since the vapor concentration we used was
near the saturation point.' This lack of teratogenicity
at three times the concentration of a teratogenic level
of its structurally similar glycol ether, points to a
relatively strict structural requirement to produce
teratogenic effects.
The present study does not elucidate the mechanism
of action by which the solvents induce embryotoxicity.
Nor did we determine biotransformation pathways,
though it is likely that each glycol ether undergoes
* One purpose of this study was to select another glycol ether for
inclusion in a behavioral teratology study. As exposure to 200 ppm
2-ethoxyethanol on gestation days 14-20 was previously reported to
cause neonatal deaths (6), small groups ofanimals were also exposed
to the chemicals in the present study on gestation days 14-20.
Maternal animals reared their young (litters culled to four female and
four male pups on the day ofbirth) to weaning, and the offspring were
weighed weekly for 5 weeks. The results indicated that 100 ppm 2-ME
(N = 6) delayed parturition by approximately 36 hr and no pups
survived for 1 week; 50ppm2-HE (N = 5)producedlittle, ifany, delay
in parturition, and all pups survived. Exposure to 600 ppm EEAC (N
= 3) delaved parturition by around 24 hr and produced 75% mortality
in the offspring; 390 ppm (N = 3) delayed parturition by about 12 hr,
but all offspring survived; neither 130 ppm EEAC (N = 4) nor 150
ppm BU (N = 4) produced any adverse effects in the offspring.
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biotransformation via alcohol and aldehyde dehydro-
genase, yielding its corresponding acetaldehyde and
subsequently excreted primarily as the acetic acid
derivative. We observed that embryotoxicity decreases
as alkyl chain length increases, similar to observations
with testicular atrophy (7). We found that short-chain
glycol ethers and their corresponding esters are
embryotoxic and teratogenic in rats. Since previous
research found similar effects induced by methoxy-
ethanol in mice via intubation (3) and ethoxyethanol in
rabbits (5) via inhalation, and in rats via cutaneous
exposure (4), teratogenic effects have been induced in
three lower species of animals by common routes of
human exposure. Such effects call for careful examina-
tion of human populations exposed to this class of
solvents, particularly since these effects in animals
were observed at concentrations which are at or below
current permissible exposure limits.
NOTE: Since the time this paper was prepared,
there has been a proliferation of research on the glycol
ethers; we refer readers to the other paper in this issue
for more recent research.
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